See more : Remedy Entertainment Oyj (REMEDY.HE) Income Statement Analysis – Financial Results
Complete financial analysis of China Catalyst Holding Co., Ltd. (688267.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Catalyst Holding Co., Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Shinfox Energy Co., Ltd. (6806.TW) Income Statement Analysis – Financial Results
- Icosavax, Inc. (ICVX) Income Statement Analysis – Financial Results
- Kirloskar Industries Limited (KIRLOSIND.BO) Income Statement Analysis – Financial Results
- Nelco Limited (NELCO.BO) Income Statement Analysis – Financial Results
- Capstone Therapeutics Corp. (CAPS) Income Statement Analysis – Financial Results
China Catalyst Holding Co., Ltd. (688267.SS)
About China Catalyst Holding Co., Ltd.
China Catalyst Holding Co., Ltd. engages in the research and development, production, and sale of zeolite catalyst, customized process package solutions, and fine chemicals in China and internationally. The company offers special molecular sieves; hydrogen peroxide to propylene oxide catalyst/HPPO, epichlorohydrin catalyst/POCL, high-purity methanol catalyst, hydrogenation of dimethyl oxalate to ethylene glycol (DEG) catalyst, ammoximation catalyst, pyridine catalyst, zeolite adsorbent for medical oxygen production, and isomerization catalyst; and fine chemicals, such as tetrapropylammonium hydroxide, N,N,N-trimethyl-1-ammonium adamantine, tetrapropylammonium hydroxide, and isopentenyl alcohol. Its products are used in environmental protection, energy, and chemical industries. The company was formerly known as Dalian Heterogeneous Catalyst Co., Ltd. and changed its name to China Catalyst Holding Co., Ltd. in November 2015. China Catalyst Holding Co., Ltd. was founded in 2008 and is based in Dalian, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 549.88M | 680.66M | 560.83M | 405.96M | 332.99M | 169.14M | 219.02M | 166.10M | 144.90M | 66.38M |
| Cost of Revenue | 369.37M | 410.84M | 307.51M | 227.10M | 211.47M | 107.33M | 146.32M | 110.89M | 106.18M | 55.00M |
| Gross Profit | 180.51M | 269.82M | 253.33M | 178.86M | 121.52M | 61.81M | 72.70M | 55.21M | 38.72M | 11.38M |
| Gross Profit Ratio | 32.83% | 39.64% | 45.17% | 44.06% | 36.49% | 36.54% | 33.19% | 33.24% | 26.72% | 17.15% |
| Research & Development | 47.53M | 49.55M | 36.97M | 28.16M | 29.66M | 22.33M | 13.29M | 9.71M | 0.00 | 2.18M |
| General & Administrative | 13.52M | 15.44M | 11.99M | 8.18M | 6.00M | 6.07M | 25.95M | 17.42M | 12.49M | 4.54M |
| Selling & Marketing | 5.07M | 12.47M | 9.63M | 6.44M | 6.83M | 6.18M | 2.17M | 1.01M | 1.39M | 981.02K |
| SG&A | 18.58M | 27.91M | 21.62M | 14.62M | 12.84M | 12.25M | 31.43M | 19.39M | 13.88M | 5.61M |
| Other Expenses | 24.41M | 37.56M | 35.23M | 15.09M | 19.68M | -27.03K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 90.53M | 115.03M | 93.82M | 57.87M | 62.17M | 54.96M | 30.15M | 20.76M | 15.00M | 5.18M |
| Cost & Expenses | 459.90M | 525.87M | 401.33M | 284.97M | 273.64M | 162.29M | 176.47M | 131.65M | 121.18M | 60.18M |
| Interest Income | 5.64M | 10.35M | 289.00K | 93.11K | 314.34K | 522.06K | 893.31K | 436.12K | 0.00 | 651.15K |
| Interest Expense | 1.79M | 6.51M | 9.88M | 8.56M | 3.23M | 2.78M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 74.39M | 68.51M | 60.52M | 32.41M | 22.75M | 21.45M | 6.23M | 5.03M | 3.09M | 162.01K |
| EBITDA | 163.18M | 247.79M | 222.02M | 144.45M | 82.67M | 30.89M | 46.02M | 39.42M | 27.86M | 5.82M |
| EBITDA Ratio | 29.68% | 37.64% | 39.20% | 30.54% | 19.57% | 10.23% | 21.01% | 23.73% | 19.22% | 8.77% |
| Operating Income | 89.98M | 158.90M | 148.26M | 105.62M | 59.47M | 8.22M | 39.79M | 34.39M | 24.77M | 5.66M |
| Operating Income Ratio | 16.36% | 23.34% | 26.44% | 26.02% | 17.86% | 4.86% | 18.17% | 20.70% | 17.09% | 8.53% |
| Total Other Income/Expenses | -2.94M | 12.09M | 2.76M | -877.97K | -624.84K | -27.03K | 3.65M | -373.43K | -28.16K | 557.01K |
| Income Before Tax | 87.04M | 170.98M | 151.02M | 104.75M | 58.84M | 8.19M | 43.44M | 34.01M | 23.72M | 5.55M |
| Income Before Tax Ratio | 15.83% | 25.12% | 26.93% | 25.80% | 17.67% | 4.84% | 19.84% | 20.48% | 16.37% | 8.36% |
| Income Tax Expense | 10.12M | 19.21M | 17.35M | 12.91M | 5.39M | -1.04M | 5.23M | 3.98M | 5.15M | 1.21M |
| Net Income | 76.91M | 151.81M | 133.67M | 91.84M | 53.45M | 9.23M | 38.21M | 30.03M | 18.57M | 4.34M |
| Net Income Ratio | 13.99% | 22.30% | 23.83% | 22.62% | 16.05% | 5.46% | 17.45% | 18.08% | 12.82% | 6.54% |
| EPS | 0.44 | 0.86 | 0.76 | 0.52 | 0.30 | 0.07 | 0.35 | 0.36 | 0.62 | 0.43 |
| EPS Diluted | 0.44 | 0.86 | 0.76 | 0.52 | 0.30 | 0.07 | 0.35 | 0.36 | 0.62 | 0.43 |
| Weighted Avg Shares Out | 174.80M | 176.20M | 176.20M | 176.20M | 176.20M | 131.82M | 109.17M | 83.43M | 29.95M | 10.10M |
| Weighted Avg Shares Out (Dil) | 174.80M | 176.20M | 176.20M | 176.20M | 176.20M | 131.82M | 109.17M | 83.43M | 29.95M | 10.10M |
Source: https://incomestatements.info
Category: Stock Reports